Top Markets
Coin of the day
Vasamed, Inc. Vasamed, Inc.

Vasamed, Inc.

VSMD
Rang in Aktien #42568
Vasamed, Inc. specializes in the development, manufacturing, licensing, and... Vasamed, Inc. specializes in the development, manufacturing, licensing, and distribution of a comprehensive suite of products, software solutions, and services focused on the assessment and management of circulatory health throughout the United States. Key among its offerings is the SensiLase PAD-IQ, a device designed to measure skin perfusion pressure, conduct pulse volume recordings, and calculate the Ankle-Brachial Index utilizing Doppler-derived pressure readings. The company also provides advanced Wound Imaging & SmartDraw systems for precise wound measurement. Additionally, Vasamed offers the PAD-IQ Studycast, a platform that facilitates the rapid and secure transmission of diagnostic test results to vascular specialists. This enables prompt interpretation of findings and supports timely, medically indicated therapeutic interventions. For safeguarding its equipment, the company also supplies a custom carrying case for the PAD-IQ system. Vasamed caters to both clinicians and patients, and has been operating since its founding in 1988. Its corporate headquarters are located in Eden Prairie, Minnesota.
Aktienkurs
$0.0001
Zuletzt synchronisiert: 2026-08-11
Marktkapitalisierung
$802.00
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Vasamed, Inc. (VSMD)

Kategorie

EPS für Vasamed, Inc. (VSMD)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von Vasamed, Inc. beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von Vasamed, Inc. von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber